Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ · Healthcare
Citius Pharmaceuticals, Inc. Shareholder Equity 2011–2022
Citius Pharmaceuticals, Inc. annual shareholder equity history from 2011 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Citius Pharmaceuticals, Inc. shareholder equity as of September 30, 2022: 102.8M, a 22.21% decrease year-over-year.
- Citius Pharmaceuticals, Inc. shareholder equity for 2022 were 102.8M, a 22.21% decrease from 2021.
- Citius Pharmaceuticals, Inc. shareholder equity for 2021 were 132.2M, a 292.57% increase from 2020.
- Citius Pharmaceuticals, Inc. shareholder equity for 2020 were 33.7M, a 24.00% increase from 2019.
- Citius Pharmaceuticals, Inc. shareholder equity for 2019 were 27.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Citius Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $103 |
| 2021 | $132 |
| 2020 | $34 |
| 2019 | $27 |
| 2018 | $31 |
| 2017 | $22 |
| 2013 | $-0 |
| 2012 | $-0 |
| 2011 | $-0 |
Citius Pharmaceuticals, Inc. Shareholder Equity — FAQ
Citius Pharmaceuticals, Inc. (CTXR) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTXR's shareholder equity history?
The chart and table above show Citius Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.